CRMD - CorMedix Inc.

QQQ $ 476.00 $ 5.61 (1.19 %)

DIA $ 416.44 $ 2.30 (0.56 %)

SPY $ 563.62 $ 5.33 (0.95 %)

TLT $ 96.60 $ -1.04 (-1.07 %)

GLD $ 231.30 $ -1.66 (-0.71 %)

Previous Close

$ 6.24

Open

Bid

$ 6.23 x 483

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 2.57 - $ 7.00

Volume

484,230

Average Volume

Market Cap

348.57M

Beta (5Y Monthly)

$ 1.80

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-12-2024	12-31-2023	10-K
4	11-14-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-15-2023	03-31-2023	10-Q
7	03-30-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-11-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-29-2022	12-31-2021	10-K
12	11-09-2021	09-30-2021	10-Q
13	08-12-2021	06-30-2021	10-Q
14	05-13-2021	03-31-2021	10-Q
15	03-30-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-10-2020	06-30-2020	10-Q
18	05-11-2020	03-31-2020	10-Q
19	03-16-2020	12-31-2019	10-K
20	11-14-2019	09-30-2019	10-Q
21	08-14-2019	06-30-2019	10-Q
22	05-13-2019	03-31-2019	10-Q
23	03-14-2019	12-31-2018	10-K
24	11-14-2018	09-30-2018	10-Q
25	08-14-2018	06-30-2018	10-Q
26	05-15-2018	03-31-2018	10-Q
27	03-19-2018	12-31-2017	10-K
28	11-09-2017	09-30-2017	10-Q
29	08-09-2017	06-30-2017	10-Q
30	05-10-2017	03-31-2017	10-Q
31	03-16-2017	12-31-2016	10-K
32	11-09-2016	09-30-2016	10-Q
33	08-04-2016	06-30-2016	10-Q
34	05-10-2016	03-31-2016	10-Q
35	03-15-2016	12-31-2015	10-K
36	11-12-2015	09-30-2015	10-Q
37	08-06-2015	06-30-2015	10-Q
38	05-07-2015	03-31-2015	10-Q
39	03-12-2015	12-31-2014	10-K
40	11-13-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

galapagos-xpeng-cormedix-and-other-big-stocks-moving-higher-on-monday

Galapagos, XPeng, CorMedix And Other Big S...
08/26/2024 13:59:41

Rodman & Renshaw Initiates Coverage On Cor...
08/26/2024 11:04:33

Rodman & Renshaw analyst Brandon Folkes initiates coverage on Cormedix (NASDAQ:CRMD) with a Buy rating and announces Pri...

RBC Capital Reiterates Outperform on Corme...
08/15/2024 14:08:49

RBC Capital analyst Gregory Renza reiterates Cormedix (NASDAQ:CRMD) with a Outperform and maintains $9 price target.

Needham Reiterates Buy on Cormedix, Mainta...
08/15/2024 09:37:01

Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

Cormedix Q2 2024 GAAP EPS $(0.25), Inline,...
08/14/2024 11:47:17

Truist Securities Maintains Buy on Cormedi...
07/25/2024 14:32:07

Truist Securities analyst Joon Lee maintains Cormedix (NASDAQ:CRMD) with a Buy and lowers the price target from $14 to $12.

Needham Reiterates Buy on Cormedix, Mainta...
06/19/2024 09:45:49

Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

CorMedix Receives FDA Support for Expanded...
06/18/2024 12:20:28

CorMedix Announces CMS Grants Pass-Through...
06/06/2024 12:34:09

CorMedix Announces Commercial Agreement Wi...
05/28/2024 12:43:16

CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseas...

Needham Reiterates Buy on Cormedix, Mainta...
05/13/2024 09:32:37

Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

Cormedix Q1 2024 GAAP EPS $(0.25) Beats $(...
05/09/2024 11:36:03

Cormedix (NASDAQ:CRMD) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.28) by 1...

CorMedix Inc. Announces CMS Grants Transit...
04/19/2024 12:31:44

CorMedix Announces U.S. Inpatient Commerci...
04/15/2024 12:40:19

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
04/12/2024 20:31:04

Two Of CorMedix Abstracts Accepted For Pre...
04/11/2024 12:37:54

JMP Securities Reiterates Market Outperfor...
04/09/2024 12:39:35

JMP Securities analyst Jason Butler reiterates Cormedix (NASDAQ:CRMD) with a Market Outperform and maintains $19 price target.

Needham Reiterates Buy on Cormedix, Mainta...
04/09/2024 10:08:10

Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

CorMedix Inc. Announces 5-Year Contract Wi...
04/08/2024 12:41:21

CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseas...

RBC Capital Maintains Outperform on Cormed...
03/13/2024 14:57:29

RBC Capital analyst Gregory Renza maintains Cormedix (NASDAQ:CRMD) with a Outperform and lowers the price target from $10 to...